Cancer statistics for the year 2020: An overview

Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram, Donald M Parkin, Marion Piñeros, Ariana Znaor, Freddie Bray, Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram, Donald M Parkin, Marion Piñeros, Ariana Znaor, Freddie Bray

Abstract

Our study briefly reviews the data sources and methods used in compiling the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for the year 2020 and summarises the main results. National estimates were calculated based on the best available data on cancer incidence from population-based cancer registries (PBCR) and mortality from the World Health Organization mortality database. Cancer incidence and mortality rates for 2020 by sex and age groups were estimated for 38 cancer sites and 185 countries or territories worldwide. There were an estimated 19.3 million (95% uncertainty interval [UI]: 19.0-19.6 million) new cases of cancer (18.1 million excluding non-melanoma skin cancer) and almost 10.0 million (95% UI: 9.7-10.2 million) deaths from cancer (9.9 million excluding non-melanoma skin cancer) worldwide in 2020. The most commonly diagnosed cancers worldwide were female breast cancer (2.26 million cases), lung (2.21) and prostate cancers (1.41); the most common causes of cancer death were lung (1.79 million deaths), liver (830000) and stomach cancers (769000).

Keywords: GLOBOCAN; cancer; global estimates; incidence; mortality.

© 2021 Union for International Cancer Control.

References

REFERENCES

    1. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-1953. .
    1. United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019, online edition, Revision 1. Accessed July 10, 2019.
    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. .
    1. Bray F, Colombet M, Ferlay J, et al., eds. Cancer Incidence in Five Continents. Vol 11 (Electronic Version). Lyon: International Agency for Research on Cancer; 2017.
    1. The African Cancer Registry Network
    1. World Health Organization. Mortality Database. Health Statistics and Information Systems. Geneva, Switzerland: WHO. Accessed January 31, 2020.
    1. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Vol 2. Geneva, Switzerland: WHO; 2014.
    1. Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-57). Sendai, Japan: Department of Public Health, Tohoku University of Medicine; 1960.
    1. Doll R, Payne P, Waterhouse JAH, eds. Cancer Incidence in Five Continents. Vol 1. Geneva, Switzerland: Union Internationale Contre le Cancer; 1966.
    1. European Cancer Information System. . Accessed October 30, 2020.
    1. Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal ML. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016 Aug 18;375(7):614-617. .
    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386. 2014.
    1. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356-387. .
    1. United Nations Development Programme. Human Development Report 2019. . Accessed January 2020.
    1. Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3(8):e2017267. .
    1. Belgium Cancer Registry Strong decline in new cancer diagnoses in April due to corona crisis in Belgium. 2020. . Accessed October 30, 2020.
    1. Soerjomataram I, Bardot A, Aitken J, Piñeros M, Znaor A, Steliarova-Foucher E, Kohler B, Bettio M, Matsuda T, de Camargo Cancela M, Mery L, Bray F. Impact of COVID-19 on population-based cancer surveillance: a cross-sectional survey. . Accessed March 15, 2021.
    1. Ursin G. Cancer registration in the era of modern oncology and GDPR. Acta Oncol. 2019;58(11):1547-1548. .

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe